Inform Diagnostics, Inc.
Inform Diagnostics, Inc., commonly referred to as Inform Diagnostics, is a leading provider of diagnostic services headquartered in the United States. Founded in 2014, the company has established a strong presence in the pathology and laboratory services industry, focusing on delivering high-quality diagnostic solutions across various operational regions. Specialising in advanced diagnostic testing, Inform Diagnostics offers a range of core services, including pathology consultations and molecular diagnostics. Their commitment to innovation and accuracy sets them apart in a competitive market, ensuring that healthcare providers receive reliable and timely results. With a reputation for excellence, Inform Diagnostics has achieved significant milestones, positioning itself as a trusted partner in the healthcare community. Their dedication to improving patient outcomes through precise diagnostics underscores their role as a key player in the industry.
DitchCarbon Score
How does Inform Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Inform Diagnostics, Inc.'s score of 36 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Inform Diagnostics, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Fulgent Genetics, Inc., which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from Inform Diagnostics, Inc. However, emissions data and performance metrics may be inherited from its parent company, Fulgent Genetics, Inc., at a cascade level of 2. This means that any climate initiatives or emissions reductions reported by Fulgent Genetics could reflect on Inform Diagnostics, although specific figures and targets are not disclosed. In the absence of direct emissions data, it is essential to monitor Fulgent Genetics for any relevant updates on sustainability practices and climate commitments that may impact Inform Diagnostics, Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 1,651,000 | 0,000,000 | 000,000 |
| Scope 2 | 1,450,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Inform Diagnostics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
